Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CNS
CNS logo

CNS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cohen & Steers Inc (CNS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
62.180
1 Day change
-1.43%
52 Week Range
83.990
Analysis Updated At
2026/03/20
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Cohen & Steers Inc (CNS) is not a strong buy at the moment for a beginner investor with a long-term focus. The technical indicators are bearish, the financial performance shows declining revenue and earnings, and there are no significant positive catalysts or trading signals to support an immediate purchase. Holding off for now is recommended.

Technical Analysis

The MACD is negative and contracting, RSI is neutral at 37.58, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Support levels are at 61.583 and 60.213, with resistance at 63.8 and 66.018. The stock is currently trading near its support levels, but there is no clear upward momentum.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
3

Positive Catalysts

  • NULL identified. No recent news or significant insider/hedge fund activity. Gross margin remained stable, but this is not a strong catalyst.

Neutral/Negative Catalysts

  • Declining financial performance in Q4 2025, with revenue down 5.55% YoY, net income down 23.88% YoY, and EPS down 23.60% YoY. No recent news or political trading activity to support the stock.

Financial Performance

In Q4 2025, revenue dropped to $115.89M (-5.55% YoY), net income dropped to $34.88M (-23.88% YoY), and EPS dropped to $0.68 (-23.60% YoY). Gross margin remained unchanged.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target updates available.

Wall Street analysts forecast CNS stock price to fall
1 Analyst Rating
Wall Street analysts forecast CNS stock price to fall
0 Buy
0 Hold
1 Sell
Moderate Sell
Current: 63.080
sliders
Low
63
Averages
63
High
63
Current: 63.080
sliders
Low
63
Averages
63
High
63
BofA
Underperform
downgrade
$71 -> $63
AI Analysis
2025-12-10
Reason
BofA
Price Target
$71 -> $63
AI Analysis
2025-12-10
downgrade
Underperform
Reason
BofA lowered the firm's price target on Cohen & Steers to $63 from $71 and keeps an Underperform rating on the shares. Looking ahead to 2026, the firm now favors the alternative asset managers to online brokers due to what it sees as a better valuation and positioning setup combined with a stronger macro backdrop, the analyst tells investors in a note on the brokers, asset managers and exchanges group.
BofA
Underperform
maintain
$68 -> $71
2025-10-21
Reason
BofA
Price Target
$68 -> $71
2025-10-21
maintain
Underperform
Reason
BofA raised the firm's price target on Cohen & Steers to $71 from $68 and keeps an Underperform rating on the shares. C&S reported better-than-expected Q3 results, including an EPS beat, and management raised the 2025 G&A growth guidance to 9%, announced $500M-$600M of pending redemptions and a $1.8B unfunded pipeline on the earnings call, the analyst tells investors. While flows appear to be improving, redemptions remain elevated and high-interest rates will continue to be a headwind, says the analyst, who maintains an Underperform rating due to challenges in real estate.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CNS
Unlock Now

People Also Watch